Hayato Mine

Fukushima, 9601295, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clinical utility of comprehensive genomic profiling in thoracic malignancies beyond conventional gene testing.

Clinical utility of comprehensive genomic profiling in thoracic malignancies beyond conventional gene testing.

Journal: International journal of clinical oncology

Published: August 22, 2025

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma.

Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma.

Journal: BMC cancer

Published: July 23, 2024

Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period.

Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period.

Journal: Cureus

Published: June 27, 2024

Successful pericardial repair and coverage for late pacemaker lead-related atrial perforation and pneumothorax: a case report.

Successful pericardial repair and coverage for late pacemaker lead-related atrial perforation and pneumothorax: a case report.

Journal: General thoracic and cardiovascular surgery cases

Published: May 05, 2023

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Journal: Biomedicines

Published: December 22, 2022

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.

Journal: Thoracic cancer

Published: June 14, 2022

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

Journal: Anticancer research

Published: October 04, 2021

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 19, 2021

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

Journal: Scientific reports

Published: March 17, 2021

A patient with ALK-positive lung adenocarcinoma who survived alectinib-refractory postoperative recurrence for 4 years by switching to ceritinib.

A patient with ALK-positive lung adenocarcinoma who survived alectinib-refractory postoperative recurrence for 4 years by switching to ceritinib.

Journal: Thoracic cancer

Published: March 15, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026